Prostate Cancer - Results from #100

Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention. January 9, 2023

Technical note: Investigating the suitability of existing facilities for a new Lu-177 prostate-specific membrane antigen therapy program. January 6, 2023

Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study. January 6, 2023

Computer-aided diagnosis in prostate cancer: a retrospective evaluation of the Watson Elementary® system for preoperative tumor characterization in patients treated with robot-assisted radical prostatectomy. January 6, 2023

Concurrent prognostic utility of lymph node count and lymph node density for men with pathological node-positive prostate cancer. January 6, 2023

Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations. January 6, 2023

Association of Androgen Deprivation Therapy with Metabolic Disease in Prostate Cancer Patients: An Updated Meta-Analysis January 5, 2023

Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer. January 5, 2023

Analysis of a biopsy-based genomic classifier in high-risk prostate cancer: Meta-analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 phase III randomized trials. January 5, 2023

Genomic classifiers in personalized prostate cancer radiotherapy approaches - a systematic review and future perspectives based on international consensus. January 5, 2023

Docetaxel Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis in Prostate Cancer Cells via Epigenetic Gene Regulation by Enhancer of Zeste Homolog 2. January 5, 2023

Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study. January 5, 2023

Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors: The JAVELIN PARP Medley Nonrandomized Controlled Trial. January 5, 2023

A Low PSA Predicts a Worse Outcome in High but Not in Low/Intermediate Grade Prostate Cancer January 4, 2023

Five-year patient reported outcomes in NRG Oncology RTOG 0938, evaluating two ultrahypofractionated regimens for prostate cancer. January 4, 2023

The function of Prostate Health Index in detecting clinically significant prostate cancer in the PI-RADS 3 population: a multicenter prospective study. January 4, 2023

Radiorecurrent prostate cancer: advantages and disadvantages of salvage radical prostatectomy. January 4, 2023

Utilization of genetic testing in men with advanced prostate cancer. January 4, 2023

The Prevalence of Low-Value Prostate Cancer Screening in Primary Care Clinics: A Study Using the National Ambulatory Medical Care Survey. January 4, 2023

A prospective, multicenter head-to-head comparative study in patients with primary high-risk prostate cancer investigating the bone lesion detection of conventional imaging and 18F-PSMA-PET/CT. January 3, 2023

Page 6 of 1276

email news signup